Excerpts

High Levels of TGFB2, IFNGR2, and Downstream Signaling Molecules Exhibited Worse OS Outcomes than Those of the Remaining Patients We next sought to characterize the upregulation of TGFB2 and IFNGR2 mRNA that was accompanied by highly significant correlations with worse OS in the population of LGG patients ( Figure 2 ).

The RAMSES-01 regimens resulted in significantly better LPFS and showed a strong trend for a higher rate of improvement of motor function.

Interestingly, this experiment showed a trend towards a difference between simultaneously treated and sequentially treated mice when analyzing both survival and ascites accumulation which, although not significant, may indicate to the importance of treatment order. 3.4.

We took a closer look at the CNVs within some genetic subgroups, and showed a trend of poorer survival in hyperdiploid cases carrying duplications in PAX5 compared to other hyperdiploid cases.

The exponential filter intensifies low-amplitude variations in the image, enabling the better distinction of subtle regions that might be significant for radiomic analysis.

Kaplan–Meier survival curves generated using quartile H-scores as cutoff values for stroma, tumor, and stroma + tumor showed a trend between higher H-score and improved prognosis ( Figure S1C–H ).

Their study revealed a significant trend toward lower grades of acute side effects in the IMPT group, encompassing dysphagia, fatigue, xerostomia, dysgeusia, oral mucositis, weight loss, and hoarseness.

Although our data show a possible trend in some such cases, the results did not reach significance.

This difference was not as substantial for CD3 + CD4 + CCR10 + Th22 cells, although responders showed a trend towards higher numbers of Th22 cells in the peripheral blood during an acute cutAE, maintaining this level during therapy ( Figure 3 E and Supplementary Table S2 ).

This prospective study, designed as an exploratory study to be followed up by larger studies in the future, compared patients with individual clinical manifestations of cutAEs and provided several significant and near-significant results that warrant follow-up.

However, a numerical trend towards better results was observed in tumors with >30% cells stained than tumors with ≤30% staining [ 2 ].

In the JACOB trial, adding pertuzumab to first-line chemotherapy plus trastuzumab in metastatic HER2-positive esophagogastric cancer failed to significantly improve overall survival in spite of a positive trend in PFS and ORR.

Methylation showed a highly significant and increasing trend with disease severity.

An ROC curve comparison of the TBR plexus in determining the glioma extent with respect to the acquisition time (PET 10 or PET 60) showed a trend to better accuracy in the early acquisitions ( Figure S4 ).

Our primary findings reveal a notable trend toward improved OS for patients treated with RFA in conjunction with plastic stents, along with improved stent patency in the RFA-treated group.

Literature suggests that around 43% of cancer patients have a negative PMI, although there is evidence of a decreasing trend in recent years [ 28 ].

In Vorarlberg, melanoma mortality reduction in the whole study period of 1985–2019, which just barely missed statistical significance, could thus be the result of both interventions during two different time intervals.

A figure in the Supplementary Data of the IMpower150 study [ 24 ] showed a trend towards benefit in the 31 patients with ALK translocations who received ABCP or BCP.

The incidence of melanoma in children increased from 1975 to 2004, but the subsequent decrease of 3.4% annually [ 12 ] is an encouraging trend. 8.

4, while the association between the G allele and metastasis does not reach conventional statistical significance, it still suggests a notable trend towards a reduced risk of metastasis associated with the G allele.

Considering the clinical context is imperative, it is essential to interpret the results cautiously, especially for genotypes or alleles with borderline significance levels.

Depending on health insurance policies, treatment and follow-up costs may be covered by health insurances, but there may be significant differences between several countries.

All publications showed a highly significant difference between the PTR and IPT groups.

Conclusions The results of the present study indicate a clear trend towards improvement in terms of the treatment quality, survival, and documentation in certified colorectal cancer centers.

The subgroup analysis showed a trend towards a slightly higher overall survival during the five-year period after certification for the patients from hospitals with a basic or priority level of medical care, without significance ( p = 0.750; p = 0.638).